Fundz

Ostentus Therapeutics, Inc reported raising $520,000 in an initial SEC Form D filing, from an offering of $770,000

PRIVATEOct 13, 2022

Amount Raised

$520,000

$520,000 sold, per SEC Form D (first sale Oct 4, 2022)

Round Type

Seed

Newport CoastHealthcare

Who to call at Ostentus Therapeutics, and when

A new round usually means Ostentus Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Ostentus Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Ostentus Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Ostentus Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Ostentus Therapeutics

Location

Newport Center Drive

Newport Coast, California, United States

About

Ostentus Therapeutics, Inc. is a pre-clinical biotechnology company investigating the activity, efficacy, and safety of its novel natural compounds in the treatment of different types of cancer and leukemia. Ostentus Therapeutics’ mission is to advance the study and development of its multicancer fighting natural compounds and demonstrate their superior efficacy and safety in humans, through rigorous pharmacological testing. Currently available options for cancer treatment involve surgical removal and radiation treatment followed by systemic chemotherapy treatment. The primarily available chemotherapeutic agents are antimetabolites (e.g., methotrexate), DNA-interactive agents (e.g., cisplatin, doxorubicin), anti-tubulin agents (e.g., taxanes), hormones, molecular targeting agents and immunotherapeutics.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Ostentus Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Ostentus Therapeutics's next move

See what Strategic adds

Ostentus Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.